Clover Health Price, Forecast, Insider, Ratings, Fundamentals & Signals

Franklin, tenn., april 23, 2024 (globe newswire) -- clover health investments, corp. (nasdaq: clov) (“clover,” “clover health” or the “company”), today announced that it will report first quarter 2024 financial results after market close on tuesday, may 7, 2024. management will host a conference call and webcast at 5:00 p.m. eastern time on may 7, 2024, to discuss the company's business and financial results.

Franklin, tenn., april 22, 2024 (globe newswire) -- clover health investments, corp. (nasdaq: clov) (“clover,” “clover health” or the “company”), a physician enablement technology company, today announced the appointment of peter kuipers as chief financial officer (“cfo”), effective as of the day after the filing of the company's quarterly report on form 10-q for the quarter-ended march 31, 2024.

Franklin, tenn., april 04, 2024 (globe newswire) -- as previously disclosed, most recently in its annual report on form 10-k for the fiscal year ended december 31, 2023, and in its quarterly report on form 10-q for the fiscal quarter ended september 30, 2023, clover health investments, corp. (the "company") has reached an agreement to resolve shareholder derivative actions pending in four jurisdictions. the actions are captioned: (1) sun v. garipalli, et al., no. 3:21-cv-0311 (m.d. tenn.); (2) in re: clover health investments corp. derivative litig., no. 1:21-cv-00191 (d. del.); (3) in re clover health investments, corp. stockholder derivative litig., index no. 655420/2021 (n.y. sup. ct., n.y...

Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through clover's home-based care model partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through clover's home-based care model

Full-year 2023 insurance mcr improved to 81.2% and fourth quarter mcr to 82.4% company improves full-year 2023 net loss by $126.2 million and full-year adjusted ebitda by $245.7 million year-over-year issues 2024 guidance with insurance mcr range of 79% - 83% and up to $20 million of adjusted ebitda profitability at the high end of the range franklin, tenn., march 12, 2024 (globe newswire) -- clover health investments, corp. (nasdaq: clov) ("clover," "clover health" or the "company"), a managed care company focused on physician enablement, today reported financial results for the fourth quarter and full year 2023.

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company's business and financial results.

Numbers frequently take center stage in the stock market's maze. However, every figure has a story of strategy, ingenuity, and resiliency behind it.

Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript

FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter and full year 2023 financial results after market close on Tuesday, March 12, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on March 12, 2024 to discuss the Company's business and financial results.

In the stock market, identifying penny stocks with massive growth potential is similar to walking on a rope between two skyscrapers. Penny stocks offer high potential returns.

There are some hidden-gem penny stocks for investors to tap into amid the broader indices, such as the S&P 500 and the Nasdaq moving higher. What goes on in the macro environment can sway the companies' valuations, which could lead to substantial gains for investors.

Some stocks silently position themselves for monumental bursts. These companies, spanning the semiconductor, healthcare and biotechnology sectors, are emerging as unseen giants with the potential for a 10X surge.

In the volatile space of penny stocks, three companies are emerging as powerhouses with breakout potential, poised for massive gains. To begin with, the first one's organic growth, the second one's data licensing prowess in liquor retail, and the third one's strategic insurance advancements are captivating the market.

A handful of companies in the volatile stock market hold the elusive key to uncharted growth. Fortunes rise and fall here, and the hunt for exceptional investments never ceases.

Zacks Medical Info Systems industry stocks like Clover Health Investments (CLOV), Talkspace (TALK) and P3 Health Partners (PIII) are expected to gain from the new normal trends.